Staar Surgical (STAA) Liabilities and Shareholders Equity (2010 - 2026)

Staar Surgical's Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $451.1 million for Q2 2026.

• Quarterly Liabilities and Shareholders Equity fell 1.37% year-over-year to $451.1 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $1.8 billion (up 18.94% YoY) and the FY2026 annual result came in at $451.7 million, up 14386.14% from the prior year.
• Liabilities and Shareholders Equity was $451.1 million for Q2 2026 at Staar Surgical, roughly flat from $451.7 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $537.6 million in Q3 2024 and bottomed at $1.3 million in Q4 2022.
• A 5-year average of $368.1 million and a median of $440.7 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
• Annual changes were most pronounced in 2025 — Liabilities and Shareholders Equity retreated 15.11% — and 2026, when it surged 14386.14%.
• Staar Surgical's Liabilities and Shareholders Equity stood at $1.3 million in 2022, then surged by 110.65% to $2.8 million in 2023, then advanced by 12.64% to $3.1 million in 2024, then soared by 14536.37% to $456.4 million in 2025, then declined by 1.15% to $451.1 million in 2026.
• Business Quant data shows STAA's Liabilities and Shareholders Equity at $451.1 million in Q2 2026, $451.7 million in Q1 2026, and $456.4 million in Q3 2025.